COMPOUND 2055269
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for COMPOUND 2055269, covering 2024-01-31 to 2024-01-31. Get the full timeline:
Most recent: Clinical Trial Update: Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma [Phase 2]